Tesamorelin
Tesamorelin
The batch you'll receive
Batch: PM-260719-TESAMORELIN-01
Lab: Janoshik
Purity: >99.95%
Test date: 12.08.2026
View this batch's certificate of analysisAbout
Specifications
Dosing
Phase III trials used 2 mg subcutaneously once daily; approved formulations deliver 1.4 mg (F4) and 1.28 mg (F8).
Full dosing guideTitration schedule · reference